ZTS Collar Strategy
ZTS (Zoetis Inc.), in the Healthcare sector, (Drug Manufacturers - General industry), listed on NYSE.
Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock.
ZTS (Zoetis Inc.) trades in the Healthcare sector, specifically Drug Manufacturers - General, with a market capitalization of approximately $30.83B, a trailing P/E of 11.74, a beta of 0.73 versus the broader market, a 52-week range of 71.45-160.48, average daily share volume of 6.6M, a public-listing history dating back to 2013, approximately 15K full-time employees. These structural characteristics shape how ZTS stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.73 places ZTS roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. The trailing P/E of 11.74 is on the value side, where IV often compresses outside event windows because forward growth expectations are already discounted into the share price. ZTS pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a collar on ZTS?
A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot.
ZTS snapshot
As of August 14, 2026, spot at $73.72, ATM IV 31.60%, IV rank 7.50%, expected move 9.06%. The collar on ZTS below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this collar structure on ZTS specifically: IV regime affects collar pricing on both sides; compressed ZTS IV at 31.60% typically pushes the short call premium to roughly offset the long put cost, with a market-implied 1-standard-deviation move of approximately 9.06% (roughly $6.68 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ZTS expiries trade a higher absolute premium for lower per-day decay. Position sizing on ZTS should anchor to the underlying notional of $73.72 per share and to the trader's directional view on ZTS stock.
ZTS collar setup
The ZTS collar below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ZTS at $73.72 on that close, the first option leg uses a $75.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ZTS chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ZTS shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $73.72 | long |
| Sell 1 | Call | $75.00 | $2.45 |
| Buy 1 | Put | $70.00 | $1.20 |
ZTS collar risk and reward
- Net Premium / Debit
- -$7,247.00
- Max Profit (per contract)
- $253.00
- Max Loss (per contract)
- -$247.00
- Breakeven(s)
- $72.47
- Risk / Reward Ratio
- 1.024
Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium.
ZTS collar payoff curve
Modeled P&L at expiration across a range of underlying prices for the collar on ZTS. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$247.00 |
| $16.31 | -77.9% | -$247.00 |
| $32.61 | -55.8% | -$247.00 |
| $48.91 | -33.7% | -$247.00 |
| $65.21 | -11.6% | -$247.00 |
| $81.50 | +10.6% | +$253.00 |
| $97.80 | +32.7% | +$253.00 |
| $114.10 | +54.8% | +$253.00 |
| $130.40 | +76.9% | +$253.00 |
| $146.70 | +99.0% | +$253.00 |
When traders use collar on ZTS
Collars on ZTS hedge an existing long ZTS stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
ZTS thesis for this collar
The market-implied 1-standard-deviation range for ZTS extends from approximately $67.04 on the downside to $80.40 on the upside. A ZTS collar hedges an existing long ZTS position with a protective put while financing the put cost via a short call; when the premiums roughly offset, the collar acts as a near-zero-cost insurance band around the current spot. Current ZTS IV rank near 7.50% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on ZTS at 31.60%. As a Healthcare name, ZTS options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ZTS-specific events.
ZTS collar positions are structurally neutral (protective); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ZTS positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ZTS alongside the broader basket even when ZTS-specific fundamentals are unchanged. Always rebuild the position from current ZTS chain quotes before placing a trade.
Frequently asked questions
- What is a collar on ZTS?
- A collar on ZTS is the collar strategy applied to ZTS (stock). The strategy is structurally neutral (protective): A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot. With ZTS stock at $73.72 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed ZTS chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are ZTS collar max profit and max loss calculated?
- Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium. For the ZTS collar priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 31.60%), the computed maximum profit is $253.00 per contract and the computed maximum loss is -$247.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a ZTS collar?
- The breakeven for the ZTS collar priced on this page is roughly $72.47 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The ZTS market-implied 1-standard-deviation expected move in the same options snapshot is approximately 9.06%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a collar on ZTS?
- Collars on ZTS hedge an existing long ZTS stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
- How does current ZTS implied volatility affect this collar?
- ZTS ATM IV is at 31.60% with IV rank near 7.50%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.